مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

235
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

164
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

1

Information Journal Paper

Title

Effects of Nebulized Albuterol in Transient Tachypnea of the Newborn A Clinical Trial

Pages

  0-0

Abstract

 Background: To date there is no effective drug treatment for Transient Tachypnea of the Newborn (TTN) and respiratory support is the only means to handle this disease. This study was performed to evaluate the effect of albuterol (Salbutamol) in improvement of respiratory distress in involved neonates. Methods: We conducted a randomized, blinded, placebo-controlled clinical trial Neonates with TTN received either Nebulized Albuterol (30 neonates) or placebo (30 neonates), and early clinical parameters were measured during and after treatment. Results: Totally 60 neonates including 31 males and 29 females, mean gestational age of 36. 9 1. 69 weeks, mean weight of 2703 589 gr, were analyzed. Respiratory distress score was significantly decreased in treatment compared to placebo group (from 5. 6 at the start to 1. 7 at the end of study vs 5. 6 to 3. 9 respectively) and the PO2 was significantly increased in neonates receiving Nebulized Albuterol compared to the placebo group (from 58. 5% at the start to 84. 8% at the end of study vs 58. 2% to 70. 2% respectively). No adverse effects were observed in either group. The duration of continuous positive airway pressure (CPAP) application was significantly decreased in the treatment group compared to the placebo group (1. 6 0. 77 vs. 3. 3 0. 98 respectively) (P = 0. 0001). Conclusions: Application of Nebulized Albuterol caused a considerable improvement in the respiratory distress of neonates at its primary hour of using via reduction of respiratory scores, duration and concentration of oxygen requirement, and duration of CPAP without any side effects. Therefore, this drug can be applied in the treatment of Transient Tachypnea of the Newborn appropriately.

Cites

References

  • No record.

    • Cite

    APA: Copy

    MUSSAVI, MIRHADI, ASADOLLAHI, KHAIROLLAH, MIRNIA, KAYVAN, & Sadeghvand, Shahram. (2017). Effects of Nebulized Albuterol in Transient Tachypnea of the Newborn A Clinical Trial. IRANIAN JOURNAL OF PEDIATRICS, 27(3), 0-0. SID. https://sid.ir/paper/716848/en

    Vancouver: Copy

    MUSSAVI MIRHADI, ASADOLLAHI KHAIROLLAH, MIRNIA KAYVAN, Sadeghvand Shahram. Effects of Nebulized Albuterol in Transient Tachypnea of the Newborn A Clinical Trial. IRANIAN JOURNAL OF PEDIATRICS[Internet]. 2017;27(3):0-0. Available from: https://sid.ir/paper/716848/en

    IEEE: Copy

    MIRHADI MUSSAVI, KHAIROLLAH ASADOLLAHI, KAYVAN MIRNIA, and Shahram Sadeghvand, “Effects of Nebulized Albuterol in Transient Tachypnea of the Newborn A Clinical Trial,” IRANIAN JOURNAL OF PEDIATRICS, vol. 27, no. 3, pp. 0–0, 2017, [Online]. Available: https://sid.ir/paper/716848/en

    Related Journal Papers

  • No record.

    • Related Seminar Papers

  • No record.

    • Related Plans

  • No record.

    • Recommended Workshops






    Move to top
    telegram sharing button
    whatsapp sharing button
    linkedin sharing button
    twitter sharing button
    email sharing button
    email sharing button
    email sharing button
    sharethis sharing button